Skip to main content
OpenTrials
Completed

NCT Number: NCT01278836

Fasciocutaneous Flaps for Leg Defects

The purpose of this study is to determine the effects of fasciocutaneous flaps for leg defects.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Limb Defects

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Kashani University Hospital

Isfahan, Iran

About this study

The fasciocutaneous flaps are tissue flaps which include skin, subcutaneous tissue, and the underlying fascia. Including the deep fascia with its prefascial and subfascial plexus enhances the circulation of these flaps. The investigators determined long-term outcomes of fasciocutaneous flap reconstruction in patients with lower limb defects.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with leg defects

Exclusion criteria

  • patients with underlying diseases

Treatment and study plan

fasciocutaneous flap

Procedure

flaps which include skin, subcutaneous tissue, and the underlying fascia.

Primary outcomes

  1. necrosis

    Time frame: at three years after surgery

Secondary outcomes

  1. venous congestion

    Time frame: at three years after surgery

Sponsors and collaborators

Lead sponsor

Isfahan University of Medical Sciences

Other

Registry information

Official study title

Study of Fasciocutaneous Flaps for Treatment of Leg Defects

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Jan 19, 2011
Registry last updated
Jan 27, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.